Patrick Hagner
4Patents
2h-index
15Co-inventors
37Inventor score
Filing activity: Feb 11, 2014 → Apr 5, 2018
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US10996215B2 | Methods for determining drug efficacy for the treatment of diffuse large B-cell lymphoma, multiple myeloma, and myeloid cancers | Physics | 3 | Active |
| US10689708B2 | Methods for treating diffuse large B-cell lymphoma and the use of biomarkers as a predictor of responsiveness to drugs | Chemistry; Metallurgy | 2 | Active |
| US9956226B2 | Methods and compounds for the inhibition of cellular proliferation | Human Necessities | 0 | Active |
| US10159675B2 | Cycling therapy using 3-(5-amino-2-methyl-4-oxo-4H-quinazolin-3-yl)-piperidine-2,6-dione | Human Necessities | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.